COVID-19 vaccine tracking: Phase III clinical trials commence for Bharat Biotech’s COVAXIN

Last updated on February 21st, 2023 at 11:39 am

Phase III clinical trials: Hyderabad based pharma giant, Bharat Biotech has announced of beginning phase III clinical trials of India’s first indigenous Covid-19 vaccine, COVAXIN. This phase will include 26,000 volunteers across 25 centres in India and is to be conducted in collaboration with the ICMR (Indian Council of Medical Research). This will make COVAXIN phase 3 trial the largest to be done in India for Covid-19 vaccine and also the first for Indian vaccine for coronavirus. 

COVAXIN is an inactivated virus and highly purified vaccine which is being developed by Bharat Biotech in collaboration with ICMR. 

The trial will include volunteers being inoculated with two intramuscular shots 28 days apart. The participants will be given random shots of a placebo or COVAXIN in a 1:1 ratio. The COVAXIN dose will be titrated to 6 mcg in each injection. The trial is double blinded, which means neither the investigators nor the participants will be aware of who has been administered with which shot. Participants are required to be over 18 years of age. COVAXIN was evaluated in around 1000 participants in phase I and II trials, and showed promising safe and efficient results of immunogenicity data. 

The volunteers will be monitored over next year to detect occurrence of Covid-19 infection, company sources reveal. 

Suchitra Ella, Bharat Biotech’s joint managing director said, “The development and clinical evaluation of COVAXIN marks a significant milestone for vaccinology in India for a novel vaccine. COVAXIN has garnered interest from several countries worldwide for supplies and introduction.” 

The vaccine is being manufactured at a BSL-3 (Biosafety level 3) high containment facility in Bharat Biotech’s vero cell manufacturing platform. 

The next big challenge that lays for government, pharma companies and healthcare professionals is making the vaccine available across India to all people and also make them willing to take the vaccine. 

Read More:- Dabangg actor declared as the Punjab Icon by election commission

CV Journalist

Dr. Neha Mathur, a distinguished member of the India Observers team, specializes in Health and Wellness. With a profound commitment to keeping our readers informed, Dr. Neha shares expert insights on health-related topics. Navigate the world of well-being with Dr. Neha's expertise and dedication to your health journey.

Recent Posts

Dubai Hosts Thrilling South Africa-West Indies Clash in T20 World Cup

ICC Women’s T20 World Cup 2024 kicked off in Dubai with an exciting face-off between…

October 4, 2024

Kick 2 Is Happening! Sajid Nadiadwala Drops First Look of Salman Khan’s Iconic Return

Salman Khan fans have something big to celebrate! Producer Sajid Nadiadwala has officially announced the…

October 4, 2024

Power Outage in Chennai on October 4: Is Your Area on the List?

Chennai will have a power cut on October 4, 2024, as reported by various news…

October 4, 2024

Google Enhances Search Engine with AI-Powered Video and Image Search

As part of the next phase in developing the company’s artificial intelligence, Google is to…

October 4, 2024

OpenAI Secures $6.6 Billion in Funding to Boost AI Research

According to the news sources like Reuters, OpenAI has successfully raised $6.6 billion in new…

October 3, 2024

Mamitha Baiju’s Dream Come True: Joining Vijay’s 69th Film

Mamitha Baiju is a talented actress known for her role in 'Premalu'. She is again…

October 3, 2024

This website uses cookies.

Read More